Simbarashe Takuva

1.6k total citations
33 papers, 412 citations indexed

About

Simbarashe Takuva is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Simbarashe Takuva has authored 33 papers receiving a total of 412 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Infectious Diseases, 11 papers in Virology and 7 papers in Epidemiology. Recurrent topics in Simbarashe Takuva's work include HIV/AIDS Research and Interventions (17 papers), HIV Research and Treatment (11 papers) and HIV/AIDS drug development and treatment (8 papers). Simbarashe Takuva is often cited by papers focused on HIV/AIDS Research and Interventions (17 papers), HIV Research and Treatment (11 papers) and HIV/AIDS drug development and treatment (8 papers). Simbarashe Takuva collaborates with scholars based in South Africa, United States and United Kingdom. Simbarashe Takuva's co-authors include Mhairi Maskew, Ian Sanne, Alana T. Brennan, Adrian Puren, Collet Dandara, Yogan Pillay, Peter J. Smith, Yuan Ren, Marelize Swart and Michelle Skelton and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and AIDS.

In The Last Decade

Simbarashe Takuva

31 papers receiving 401 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Simbarashe Takuva South Africa 12 290 182 96 77 38 33 412
Brandon Klein United States 9 356 1.2× 177 1.0× 157 1.6× 32 0.4× 37 1.0× 33 471
Robert Soudré Burkina Faso 11 201 0.7× 110 0.6× 127 1.3× 36 0.5× 68 1.8× 18 324
Mar Vera Spain 12 269 0.9× 171 0.9× 133 1.4× 78 1.0× 52 1.4× 29 457
Merlin Robb United States 8 268 0.9× 261 1.4× 164 1.7× 38 0.5× 70 1.8× 11 546
Praveen Kumar Naik India 13 425 1.5× 117 0.6× 287 3.0× 70 0.9× 43 1.1× 30 569
Manoranjan Midde India 13 433 1.5× 117 0.6× 296 3.1× 70 0.9× 43 1.1× 33 587
Raghavakalyan Pakam India 11 301 1.0× 95 0.5× 215 2.2× 53 0.7× 36 0.9× 20 425
Jenny Coley United States 9 197 0.7× 94 0.5× 90 0.9× 95 1.2× 82 2.2× 11 385
Jonathan Lehe United States 8 502 1.7× 322 1.8× 201 2.1× 47 0.6× 100 2.6× 10 625
Renato Maserati Italy 14 263 0.9× 236 1.3× 139 1.4× 30 0.4× 16 0.4× 24 452

Countries citing papers authored by Simbarashe Takuva

Since Specialization
Citations

This map shows the geographic impact of Simbarashe Takuva's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simbarashe Takuva with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simbarashe Takuva more than expected).

Fields of papers citing papers by Simbarashe Takuva

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simbarashe Takuva. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simbarashe Takuva. The network helps show where Simbarashe Takuva may publish in the future.

Co-authorship network of co-authors of Simbarashe Takuva

This figure shows the co-authorship network connecting the top 25 collaborators of Simbarashe Takuva. A scholar is included among the top collaborators of Simbarashe Takuva based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simbarashe Takuva. Simbarashe Takuva is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Musekiwa, Alfred, et al.. (2024). Predictors of tuberculosis treatment outcome at Senkatana clinic in Lesotho. Pan African Medical Journal. 49. 91–91.
3.
Jacobson, Barry, Elise Schapkaitz, Azwidihwi Takalani, et al.. (2023). Vascular thrombosis after single dose Ad26.COV2.S vaccine in healthcare workers in South Africa: open label, single arm, phase 3B study (Sisonke study). SHILAP Revista de lepidopterología. 2(1). e000302–e000302. 4 indexed citations
4.
Goga, Ameena, Linda‐Gail Bekker, Nigel Garrett, et al.. (2022). Sisonke phase 3B open-label study: Lessons learnt for national and global vaccination scale-up during epidemics. South African Medical Journal. 112(5b). 375–383. 4 indexed citations
5.
Takuva, Simbarashe, et al.. (2021). Knowledge, attitudes, and perceptions of long‐acting reversible contraceptive methods among healthcare workers in sub‐Saharan Africa. Tropical Medicine & International Health. 26(8). 840–861. 3 indexed citations
6.
Peter, Jonny, Simbarashe Takuva, Azwidihwi Takalani, et al.. (2021). Allergic reactions to the Ad26.COV2.S vaccine in South Africa. Journal of Allergy and Clinical Immunology Global. 1(1). 2–8. 5 indexed citations
7.
Zampoli, Marco, et al.. (2021). Clinical correlations to distinguish severe from milder forms of obstructive sleep apnoea syndrome using overnight oximetry for prioritising adenotonsillectomy in a limited-resource setting. International Journal of Pediatric Otorhinolaryngology. 152. 110988–110988. 2 indexed citations
8.
Goga, Ameena, Linda‐Gail Bekker, Nigel Garrett, et al.. (2021). Sisonke phase 3B open-label study: Lessons learnt for national and global vaccination scale-up during epidemics.. PubMed. 112(2b). 13486–13486. 3 indexed citations
9.
Kufa, Tendesayi, Zara Shubber, William MacLeod, et al.. (2019). CD4 count recovery and associated factors among individuals enrolled in the South African antiretroviral therapy programme: An analysis of national laboratory based data. PLoS ONE. 14(5). e0217742–e0217742. 20 indexed citations
10.
Hunt, Gillian, E. Kainne Dokubo, Simbarashe Takuva, et al.. (2017). Rates of virological suppression and drug resistance in adult HIV-1-positive patients attending primary healthcare facilities in KwaZulu-Natal, South Africa. Journal of Antimicrobial Chemotherapy. 72(11). 3222–3222. 4 indexed citations
11.
Kuonza, Lazarus, et al.. (2016). Decline in syphilis seroprevalence among females of reproductive age in Northern Cape Province, South Africa, 2003–2012: utility of laboratory-based information. International Journal of STD & AIDS. 28(6). 564–572. 7 indexed citations
12.
13.
Takuva, Simbarashe, Alison Brown, Yogan Pillay, Valérie Delpech, & Adrian Puren. (2016). The continuum of HIV care in South Africa. AIDS. 31(4). 545–552. 39 indexed citations
14.
Skingsley, Andrew, Simbarashe Takuva, Alison Brown, Valérie Delpech, & Adrian Puren. (2015). Monitoring HIV-Related Mortality in South Africa: The challenges and urgency. 2 indexed citations
15.
Takuva, Simbarashe, Owen Mugurungi, Junior Mutsvangwa, et al.. (2014). Etiology and Antimicrobial Susceptibility of Pathogens Responsible for Urethral Discharge Among Men in Harare, Zimbabwe. Sexually Transmitted Diseases. 41(12). 713–717. 20 indexed citations
16.
Ndlovu, Zibusiso, Tobias Chirwa, & Simbarashe Takuva. (2014). Incidence and predictors of recovery from anaemia within an HIV-infected South African Cohort, 2004-2010. Pan African Medical Journal. 19. 114–114. 13 indexed citations
17.
Takuva, Simbarashe, Denise Evans, Khangelani Zuma, Velephi Okello, & Goedele Louwagie. (2013). Comparative durability of nevirapine versus efavirenz in first-line regimens during the first year of initiating antiretroviral therapy among Swaziland HIV-infected adults. Pan African Medical Journal. 15. 5–5. 6 indexed citations
18.
Swart, Marelize, Michelle Skelton, Yuan Ren, et al.. (2013). High predictive value of CYP2B6 SNPs for steady-state plasma efavirenz levels in South African HIV/AIDS patients. Pharmacogenetics and Genomics. 23(8). 415–427. 58 indexed citations
20.
Takuva, Simbarashe, Goedele Louwagie, & Khangelani Zuma. (2012). Durability of First Line Antiretroviral Therapy: Reasons and Predictive Factors for Modifications in a Swaziland Cohort. Journal of Antivirals & Antiretrovirals. 4(1). 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026